Search Results 8191-8200 of 28419 for oral

  1. 'Start low, go slow' still applies for pain management, especially for older patients

    Mayo Clinic Radio: Colorectal cancer / peripheral neuropathy / oral health and your heart. Related Articles. Mayo Clinic researcher brings new clarity to ...

  2. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    Low dose steroids (oral prednisone or equivalent ≤ 20 mg per day), hormonal therapy for prostate cancer or breast cancer (in adjuvant situation), and ...

  3. Echocardiogram Clinical Trials - Mayo Clinic Research

    ... oral anticoagulation therapy vs. placebo for a 6 week period. A Study of Transthoracic Echocardographic Assessment for Pulmonary Artery Pressure ...

  4. Publications - Heather M. Clark, Ph.D. - Mayo Clinic

    Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease. Neurology. 2024 Aug 27; 103 (4): ...

  5. Jaw tumors and cysts - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  6. Premature birth - Diagnosis and treatment - Mayo Clinic

    BMC Oral Health. 2022; doi:10.1186/s12903-022-02504-8. Halperson E, et al. Developmental defects of enamel in children born preterm. Frontiers in Pediatrics ...

  7. Head and Neck Cancer Center - Doctors - Mayo Clinic

    ... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Oropharyngeal cancer, Radiation injury, Hypopharyngeal cancer. Show more areas of focus for ...

  8. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    Neratinib is a recently discovered oral drug that may stop breast cancer cells from growing abnormally by inhibiting (or blocking) members of a family of ...

  9. Emergency Medicine - Clinical trials

    ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

  10. Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation - Mayo Clinic

    ... oral medications. 6. History of malignant small bowel obstruction. 7. Clinically significant ascites, defined as palpable on exam or requiring a ...